Campaigns are in market. Content is shipping. The team is busy. Pipeline is flat and the quarterly forecast is slipping. Activity and outcomes have detached. The fix is almost never more activity. It is a diagnostic that separates what is executing from what is actually producing.
Built for Series B SaaS VPs of Marketing, bootstrapped B2B founders carrying marketing themselves, and manufacturing CEOs with a marketing function that has lost its grip on pipeline. Applies to any leader where marketing cost is visible and marketing impact is not.
A $5,000 fixed-scope diagnostic delivered in 10 business days. Produces a 20 to 30 page strategy document and a 90-minute executive session that reconnects activity to pipeline outcome.
When marketing is running and pipeline is flat, the cause is almost always one of three. The ICP has shifted and the targeting has not. The positioning fails the qualified buyer before they self-identify. Or the reporting tracks activity (clicks, opens, form fills) instead of outcome (qualified opportunities). Madison Logic's 2024 pipeline-failure research and McKinsey's 2024 B2B Pulse data both point to the same root: the brief is wrong, not the execution. The Strategy Diagnostic identifies which is binding within ten business days and sequences the fix.
of the B2B buying journey is complete before the buyer ever contacts a vendor. The page is doing the convincing the rep used to do.
Gartner · Future of B2B Sales · 2024
of marketing-qualified leads never convert. Around 73 percent are never contacted by a sales rep. The handoff is where pipeline dies.
Forrester / Madison Logic · 2024
people on the average B2B buying committee, across 10-plus interactions. One page no longer speaks to one buyer.
McKinsey · B2B Pulse · 2024
These three numbers together describe the modern B2B buyer. The page is reading them. The deck is reading them. The pricing is reading them. The rep is the last surface they touch, not the first. If pipeline is flat, the upstream surfaces are doing the wrong job.
The buyer needs to know whether demand is weak, qualification is wrong, or the business is measuring activity instead of opportunity creation.
Campaigns, content, events, or outreach are happening, but the opportunity number does not move with the effort.
The work may be reaching people, but not the right people with the right commercial reason to act now.
Usually no. The first move is to diagnose the architecture before blaming the execution layer.
The diagnostic tests positioning, ICP, channel mix, and measurement together instead of treating pipeline as a channel-only issue.
The company has moved upmarket or adjacent, and the marketing targeting still reflects the founding-era buyer. Campaigns produce form fills from the wrong segment. Sales disqualifies most of them. Pipeline stagnates while the dashboard looks full. The fix is a forced reckoning with who is actually buying at current price point, in what volume, and why.
Sharp positioning does two jobs. It attracts the right buyer. It repels the wrong one. Generic positioning does neither. Qualified buyers cannot tell whether the offer applies to them. Unqualified buyers cannot tell whether it does not. Volume looks fine. Quality falls off. Pipeline flattens because the funnel is filled with noise.
Reporting shows the team is busy. Campaigns shipped. Posts published. Form fills collected. None of those are pipeline. When the measurement framework stops tracking the handoff from marketing to sales and the close rate by source, the team optimizes toward activity visibility instead of revenue contribution. The diagnostic restores the outcome-to-activity chain.
No invented benchmarks. Every line in the table below has a publisher, a year, and a public URL in the citations section at the bottom of this page.
| Source | Year | Finding relevant to flat pipeline |
|---|---|---|
| Gartner · Future of B2B Sales | 2024 | Around 70% of buying journey complete before vendor contact. The page does the convincing the rep used to do. |
| McKinsey · B2B Pulse Survey | 2024 | B2B buying committees average 10 people, 10+ interactions, hybrid channels. Single-buyer pages misread the room. |
| Madison Logic · Pipeline Failure | 2024 | Lead handoff between marketing and sales is the single most common point of pipeline failure. |
| Forrester / Marketo composite | 2023 | ~79% of marketing leads never convert. ~73% never contacted by a sales rep at all. |
| TrustRadius · B2B Buying Disconnect | 2023 | Only 38% match rate between vendor self-description and buyer experience of the product. |
| HBR · B2B Elements of Value | 2018 | 40 distinct B2B value elements. Vendors over-index on functional, under-index on inspirational and individual value. |
| Piotr Krzyzek · Pipeline Problem essay | 2024 | Most B2B service firms do not have a marketing problem. They have a pipeline definition and measurement problem. |
| Pavilion · State of Marketing | 2024 | Fractional CMO retainers $12K–$25K per month. Diagnostic-first engagements outperform retainer-first. |
"Of the 40 elements of value in B2B, the ones that drive purchase decisions are rarely the ones vendors emphasize. Functional elements like product quality and price are necessary. Inspirational and individual elements like vision, hope, and reduced anxiety differentiate."Almquist · Cleghorn · Sherer · Harvard Business Review · March 2018
The $5,000 Strategy Diagnostic is the correct entry point for a stalled-pipeline symptom. It runs 10 business days. It produces a 20 to 30 page written strategy covering positioning gaps, ICP definition by cohort, go-to-market motion assessment, paid acquisition audit, and a sequenced 90-day priority list. Delivered with a 90-minute executive session.
If the pipeline problem requires ongoing strategic support rather than a one-time reset, the $4,500 per month Strategy Partnership is the correct next step after the diagnostic completes. Most clients run the diagnostic first, execute the 90-day plan in-house, and move into the partnership only if the strategic question remains live.
Start the Strategy Diagnostic · $5,000 →Separate the top of funnel from the bottom. If marketing qualified leads are landing at expected volume but not progressing to stage two, the issue is handoff or sales qualification, not marketing. If MQL volume is down, the issue is upstream: targeting, positioning, or channel mix. The Strategy Diagnostic runs both analyses in parallel and identifies which of the two is binding.
Campaign activity is not the same as pipeline creation. Three common causes. The campaigns target the wrong audience segment and generate clicks that will never close. The messaging fails the qualified buyer before they self-identify. Or the campaigns are optimized for form fills, and form fills at current qualification standards do not translate to opportunities.
Content and channel mix are downstream of ICP and positioning. If the ICP is defined correctly and the positioning is sharp, both content and channel selection follow naturally. If pipeline is flat despite content and channel activity, the fix is almost never more content or a different channel. It is upstream: who the buyer actually is, and why they should choose you now.
At Series B, stalled inbound usually signals one of three things. The ICP has shifted as the company moved upmarket and marketing is still targeting the old profile. The category conversation has evolved and the positioning has not. Or the content engine is producing volume without authority. The diagnostic examines all three and sequences the fix across 90 days.
The Strategy Diagnostic is a $5,000 fixed-scope engagement producing a 20 to 30 page strategy document and a 90-minute executive session within 10 business days. The Partnership is $4,500 per month for ongoing strategic support after the diagnostic work is complete. Most pipeline-stalled clients run the diagnostic first, then either execute in-house or move into the partnership for quarterly strategic review.
This is the most common failure pattern on Reddit's r/SaaS and r/marketing threads about stalled pipeline. The agency executes against the brief. The brief encodes a positioning, ICP, or success metric that does not match where the business actually is now. A new agency does not fix it. A rewritten brief does. The Strategy Diagnostic produces the rewritten brief in 10 business days for $5,000 flat. You take the brief to whichever team is going to execute it.
A fractional CMO runs $12,000 to $25,000 per month for B2B SaaS at $2M to $30M ARR per Pavilion's 2024 compensation data. They are strong when you already have a marketing team that needs direction and weaker when you need a one-time strategic reset. If pipeline is flat because the brief is wrong, the diagnostic gives you the rewritten brief for less than half of one month of CMO retainer. If you still need ongoing execution leadership after that, hire the CMO with the brief in hand.
Yes, with different emphasis. Bootstrapped founders usually need the diagnostic to separate founder-led selling from marketing-generated pipeline so the founder can stop being the only source of new revenue. Manufacturing CEOs usually need the diagnostic to reconcile a long sales cycle with a marketing function measured on short-cycle metrics. Both are strategic direction problems, not execution problems.
Marketing Strategy Diagnostic · $5,000 flat · 10 business days · Written strategy document, 90-minute executive session, and a sequenced 90-day priority plan.